menu
    • menu

    Company profile for Neopharmed Gentili

    NEW Drugs in Dev: 1
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Neopharmed Gentili, an Italian pharmaceutical company with deep historical roots in its local region, is currently undergoing international expansion. Specializing in marketing solutions of high therapeutic value, the company offers products with significant impact across various therapeutic areas. This emphasis on solutions with tangible benefits underscores Neopharmed Gentili's commitment to providing effective medical inter...
    Neopharmed Gentili, an Italian pharmaceutical company with deep historical roots in its local region, is currently undergoing international expansion. Specializing in marketing solutions of high therapeutic value, the company offers products with significant impact across various therapeutic areas. This emphasis on solutions with tangible benefits underscores Neopharmed Gentili's commitment to providing effective medical interventions that address diverse healthcare needs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Neopharmed GentiliItaly Flag
    Country
    Country
    Italy
    Address
    Address
    Via SG Cottolengo, 15 20143 Milan
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neogen.it/it/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/neopharmed-gentili-s.p.a.
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    BioCryst Signs European License for Navenibart in Angioedema
    BioCryst Signs European License for Navenibart in Angioedema

    04 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/04/3286545/29446/en/biocryst-announces-european-licensing-agreement-with-irish-affiliate-of-neopharmed-gentili-for-navenibart-in-hereditary-angioedema.html

    GLOBENEWSWIRE
    04 May 2026
    Share Share
    Lupin Signs Licensing Deal With Neopharmed For Plasil
    Lupin Signs Licensing Deal With Neopharmed For Plasil

    18 Dec 2025

    // PRESS RELEASE

    https://www.lupin.com/lupin-signs-exclusive-licensing-agreement-with-neopharmed-for-gastroenterology-brand-plasil-in-the-philippines-and-brazil/

    PRESS RELEASE
    18 Dec 2025
    Share Share
    BioCryst Sells European ORLADEYO Business to Neopharmed Gentili
    BioCryst Sells European ORLADEYO Business to Neopharmed Gentili

    27 Jun 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/06/27/3106473/29446/en/BioCryst-Announces-Sale-of-European-ORLADEYO-berotralstat-Business-to-Neopharmed-Gentili-for-up-to-264-Million.html

    GLOBENEWSWIRE
    27 Jun 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search